<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01319643</url>
  </required_header>
  <id_info>
    <org_study_id>OXYGEN-TIPO-1.0-30-09-2009</org_study_id>
    <secondary_id>2009-016506-17</secondary_id>
    <nct_id>NCT01319643</nct_id>
  </id_info>
  <brief_title>Normal Oxygenation Versus Hyperoxia in the Intensive Care Unit (ICU)</brief_title>
  <acronym>OXYGEN-ICU</acronym>
  <official_title>Normal Oxygenation Maintenance in Intensive Care Unit: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Modena and Reggio Emilia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Modena and Reggio Emilia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Oxygen administration is a common practice in intensive care units, although concern is
      growing about oxygen toxicity. The aim of the study is to access whether a rigorous
      maintenance of a state of normal oxygenation in critically ill patients could obtain better
      outcomes, such as mortality, infections and organ failures, in comparison to conventional
      oxygen therapy practice.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2009</start_date>
  <completion_date type="Anticipated">November 2011</completion_date>
  <primary_completion_date type="Anticipated">November 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality in ICU</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of organ dysfunctions (respiratory, circulation, renal, liver)</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of nosocomial blood and respiratory infections in intensive care unit and surgery site infections in hospital.</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">660</enrollment>
  <condition>Nervous System Diseases</condition>
  <condition>Respiratory Tract Diseases</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Immune System Diseases</condition>
  <arm_group>
    <arm_group_label>Oxygenation, rigorous normal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients admitted in intensive care unit for 3 days. Administration of the lowest inspiratory fraction dose of oxygen to maintain oxygen peripheral saturation (SpO2) between 94 and 98% or an arterial partial pressure of oxygen (PaO2) between 70 and 100 mmHg. No oxygen addition administer for transports or diagnostic manoeuvres. Conventional clinical criteria for airways control and ventilation technique.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxygen, free conventional</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients admitted in intensive care units for 3 days. Administration of oxygen inspiratory fractions to maintain SpO2 over 97%, up to a PaO2 of 150 mmHg. Oxygen addition administer for transports or diagnostic manoeuvres. Conventional clinical criteria for airways control and ventilation technique.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxygen</intervention_name>
    <description>The lowest inspiratory fraction of oxygen between 21 and 100% in as a short time as possible to maintain SpO2 between 94 and 98% or PaO2 between 70 and 100 mmHg.</description>
    <arm_group_label>Oxygenation, rigorous normal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients admitted in a post-operative and medical intensive care unit with
             expected admission of at least three days. Informed consensus as soon as possible

        Exclusion Criteria:

          -  minority

          -  patient discharged from ICU and successively re-admitted

          -  patient enrolled in other studies

          -  expected survival shorter than 24 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Massimo Girardis, PD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università di Modena e Reggio Emilia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Terapia Intensiva Post-operatoria. Azienda Ospedaliero Universitaria Policlinico di Modena</name>
      <address>
        <city>Modena</city>
        <zip>41124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Massimo Girardis, PD</last_name>
      <phone>0594224934</phone>
      <phone_ext>0039</phone_ext>
      <email>girardis.massimo@unimore.it</email>
    </contact>
    <contact_backup>
      <last_name>Laura Rinaldi, MD</last_name>
      <phone>0594224896</phone>
      <phone_ext>0039</phone_ext>
      <email>rinaldi.laura@unimore.it</email>
    </contact_backup>
    <investigator>
      <last_name>Stefano Busani, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Rinaldi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2010</study_first_submitted>
  <study_first_submitted_qc>March 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2011</study_first_posted>
  <last_update_submitted>March 21, 2011</last_update_submitted>
  <last_update_submitted_qc>March 21, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 22, 2011</last_update_posted>
  <responsible_party>
    <name_title>Massimo Girardis</name_title>
    <organization>Università di Modena e Reggio Emilia</organization>
  </responsible_party>
  <keyword>Oxygen</keyword>
  <keyword>Hyperoxia</keyword>
  <keyword>Intensive care unit</keyword>
  <keyword>Mortality</keyword>
  <keyword>Organ dysfunction</keyword>
  <keyword>Postoperative care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
    <mesh_term>Immune System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

